|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 00973295.9 (espacenet) (Federated) (European Patent Register), 20001013 | | Patent/reg. no. and date | DK/EP 1274427, 20050921 | | Publication date | 20030115 | | Priority no. and date | SE 9903831, 19991022 | | EP pub. no. and date |
EP 1274427 20030115 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | BRÜLLS, Mikael, AstraZeneca R & D Mölndal
S-431 83 Mölndal, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 47/30 (2006.01) | | Title | Formulering af substituerede benzimidazoler | | Int. application no. | SE2000001992 | | Int. publication no. | WO2001028558 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
